A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder
NCT00321477
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Incontinence, Urinary and Urinary Bladder, Overactive
Overactive Bladder
Interventions
DRUG:
GW679769 oral tablets
Sponsor
GlaxoSmithKline